Applied Dna Sciences Stock Price Prediction

APDN Stock  USD 0.15  0.01  6.25%   
The relative strength index (RSI) of Applied DNA's share price is below 30 as of today. This suggests that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Applied DNA Sciences, making its price go up or down.

Oversold Vs Overbought

26

 
Oversold
 
Overbought
The successful prediction of Applied DNA's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Applied DNA Sciences, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Applied DNA's stock price prediction:
EPS Estimate Next Quarter
(0.30)
EPS Estimate Next Year
(1.22)
Wall Street Target Price
1.5
EPS Estimate Current Quarter
(0.35)
Quarterly Revenue Growth
(0.73)
Using Applied DNA hype-based prediction, you can estimate the value of Applied DNA Sciences from the perspective of Applied DNA response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Applied DNA to buy its stock at a price that has no basis in reality. In that case, they are not buying Applied because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Applied DNA after-hype prediction price

    
  USD 0.11  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Applied DNA Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Applied DNA's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.050.9911.94
Details
1 Analysts
Consensus
LowTargetHigh
3.193.503.89
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Applied DNA After-Hype Price Prediction Density Analysis

As far as predicting the price of Applied DNA at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Applied DNA or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Applied DNA, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Applied DNA Estimiated After-Hype Price Volatility

In the context of predicting Applied DNA's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Applied DNA's historical news coverage. Applied DNA's after-hype downside and upside margins for the prediction period are 0.01 and 11.06, respectively. We have considered Applied DNA's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.15
0.11
After-hype Price
11.06
Upside
Applied DNA is out of control at this time. Analysis and calculation of next after-hype price of Applied DNA Sciences is based on 3 months time horizon.

Applied DNA Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Applied DNA is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Applied DNA backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Applied DNA, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  2.88 
10.95
  0.37 
  0.21 
6 Events / Month
10 Events / Month
In about 6 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.15
0.11
25.77 
8,423  
Notes

Applied DNA Hype Timeline

Applied DNA Sciences is presently traded for 0.15. The entity has historical hype elasticity of -0.37, and average elasticity to hype of competition of 0.21. Applied is forecasted to decline in value after the next headline, with the price expected to drop to 0.11. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -25.77%, whereas the daily expected return is presently at -2.88%. The volatility of related hype on Applied DNA is about 15103.45%, with the expected price after the next announcement by competition of 0.36. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Applied DNA Sciences recorded a loss per share of 7.5. The entity last dividend was issued on the 1st of November 2019. The firm had 1:20 split on the 25th of April 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 6 days.
Check out Applied DNA Basic Forecasting Models to cross-verify your projections.

Applied DNA Related Hype Analysis

Having access to credible news sources related to Applied DNA's direct competition is more important than ever and may enhance your ability to predict Applied DNA's future price movements. Getting to know how Applied DNA's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Applied DNA may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BDSXBiodesix 0.01 8 per month 0.00 (0.1) 5.95 (5.61) 29.48 
DRIODarioHealth Corp(0.02)10 per month 4.60 (0.01) 9.72 (7.00) 27.55 
OLKOlink Holding AB 0.01 10 per month 0.48  0.04  1.58 (1.37) 4.37 
GTHGenetron Holdings(0.02)1 per month 2.49 (0.04) 3.45 (4.08) 14.43 
XGNExagen Inc(0.07)8 per month 3.40  0.09  9.62 (6.46) 25.65 
BNRBurning Rock Biotech 0.35 3 per month 7.80  0.05  16.01 (7.67) 46.14 
STIMNeuronetics(0.08)7 per month 7.44  0.05  8.99 (9.24) 59.07 
SERASera Prognostics 1.07 9 per month 4.58 (0) 9.55 (7.60) 27.67 
OCXOncoCyte Corp 0.02 9 per month 0.00 (0.15) 4.59 (4.76) 18.12 
PSNLPersonalis 0.58 9 per month 0.00 (0.08) 8.46 (9.47) 35.38 
IDXGInterpace Biosciences 0.00 0 per month 9.49  0.12  18.81 (16.19) 194.90 
ISPCiSpecimen(0.59)6 per month 0.00 (0.03) 15.80 (10.25) 64.03 
TRIBTrinity Biotech plc(0.05)9 per month 0.00 (0.16) 13.33 (8.29) 28.71 
MYNZMainz Biomed BV 0.01 8 per month 0.00 (0.05) 13.04 (10.71) 46.82 
PREPrenetics Global 0.08 7 per month 4.37 (0) 9.93 (7.40) 28.16 
FONRFonar(0.14)6 per month 0.00 (0.08) 2.15 (2.97) 10.84 

Applied DNA Additional Predictive Modules

Most predictive techniques to examine Applied price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Applied using various technical indicators. When you analyze Applied charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Applied DNA Predictive Indicators

The successful prediction of Applied DNA stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Applied DNA Sciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Applied DNA based on analysis of Applied DNA hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Applied DNA's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Applied DNA's related companies.
 2023 2024 (projected)
Dividend Yield0.0097790.00872
Price To Sales Ratio1.361.29

Story Coverage note for Applied DNA

The number of cover stories for Applied DNA depends on current market conditions and Applied DNA's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Applied DNA is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Applied DNA's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Applied DNA Short Properties

Applied DNA's future price predictability will typically decrease when Applied DNA's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Applied DNA Sciences often depends not only on the future outlook of the potential Applied DNA's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Applied DNA's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding653.8 K
Cash And Short Term Investments7.2 M
When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock:
Check out Applied DNA Basic Forecasting Models to cross-verify your projections.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(7.50)
Revenue Per Share
2.202
Quarterly Revenue Growth
(0.73)
Return On Assets
(0.57)
Return On Equity
(0.76)
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.